Skip to main content
Equibles

Caption Management, LLC

Position in CRMD — CorMedix Inc.

CIK 1706766 OKLAHOMA CITY, OK
Back to CRMD Full portfolio

Position in CRMD

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$50,083
+$50,083 QoQ
Shares Held
6,380
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#152
of 194 holders
Holding Since
Mar 2025
3 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CRMD Over Time

Shares Held

Position Value (USD)

Derivatives in CRMD

reported options exposure · as of Mar 31, 2026
CallValue
$1,552,194
CallShares
228,600
PutValue
$86,912
PutShares
12,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Caption Management, LLC holds $249,760,911 across 78 Biotechnology names. CRMD ranks #74 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 CGON
CG Oncology, Inc.
 484,461 $34,420,954
2 INSM
INSMED Inc
 236,000 $25,162,320
3 ERAS
Erasca, Inc.
 1,041,225 $19,075,242
4 CELC
Celcuity Inc.
 170,000 $17,785,400
5 DSGN
Design Therapeutics, Inc.
 1,118,098 $16,178,878
6 MLYS
Mineralys Therapeutics, Inc.
 413,087 $11,145,087
7 REPL
Replimune Group, Inc.
 783,873 $8,677,474
8 TARS
Tarsus Pharmaceuticals, Inc.
 120,700 $7,596,858

All Filings in CRMD

Export CSV
4 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $50,083 6,380
2026-03-31 $86,912 12,800
2026-03-31 $1,552,194 228,600
2025-03-31 $113,399 18,409